World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12612000413820
Date of registration: 13/04/2012
Prospective Registration: Yes
Primary sponsor: Gennimatas General Hospital of Thessaloniki
Public title: Results after Millin prostatectomy in patients with benign prostate enlargement.
Scientific title: Quality of life, urinary symptoms and erectile function in patients with benign prostate enlargement before and after Millin prostatectomy.
Date of first enrolment: 01/06/2012
Target sample size: 50
Recruitment status: Not yet recruiting
URL:  https://anzctr.org.au/ACTRN12612000413820.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Non-randomised trial; Assignment: Single group;  
Phase: 
Countries of recruitment
Greece
Contacts
Name: Kampantais Spyridon   
Address:  41 Ethnikis Aminis Street, Thessaloniki, 54643 Greece
Telephone: +30 6945375525
Email: kabspir@hotmail.com
Affiliation: 
Name: Kampantais Spyridon   
Address:  41 Ethnikis Aminis Street, Thessaloniki, 54643 Greece
Telephone: +30 6945375525
Email: kabspir@hotmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. An ability to communicate
2. An ability to understand and comply with study requirements.
3. Prostatic adenoma greater than 80 ml estimated by transrectal ultrasound (TRUS)

Exclusion criteria: 1. Other urinary diseases (e.g. Peyronie's disease, prostate cancer, urethral stricture, neurogenic bladder).

Age minimum: 50 Years
Age maximum: No limit
Gender: Males
Health Condition(s) or Problem(s) studied
Benign prostate hypertrophy;
Benign prostate hypertrophy
Renal and Urogenital - Other renal and urogenital disorders
Intervention(s)
Millin prostatectomy for benign prostate enlargement. The approximate duration of the procedure is anticipated to be 60-90 minutes. Millin prostatectomy involves a transcapsular dissection of the prostatic adenoma, instead of a transvesical approach.
Primary Outcome(s)
Quality of life before and after Millin prostatectomy. This is going to be assessed by a single question: "If you were to spend the rest of your life with your urinary condition the way it is now, how yould you feel about that? Delighted (0) / Pleased (1) / Mostly satisfied (2) / Mixed about equally satisfied and disatisfied (3) / Mostly disatified (4) / Unhappy (5) / Terrible (6)"[On day before the surgery and on 6 months.]
Erectile function before and after Millin prostatectomy. This is going to be assessed using the International Index of Erectile Function (IIEF) questionnaire.[On day before the surgery and on 6 months.]
Urinary symptoms before and after Millin prostatectomy. This is going to be assessed using the International Prostate Symptom Score (IPSS) questionnaire.[On day before the surgery and on 6 months.]
Secondary Outcome(s)
Obstructive urinary symptoms before and after Millin prostatectomy. This is going to be assessed using the International Prostate Symptom Score (IPSS) questionnaire.[On day before the surgery and on 6 months.]
Irritative urinary symptoms before and after Millin prostatectomy. This is going to be assessed using the International Prostate Symptom Score (IPSS) questionnaire.[On day before the surgery and on 6 months.]
Identification of the most important prognostic factors for the outcome (age, tobacco use, dibetes mellitus, coronary disease, alcohol). This is going to be assessed using the International Prostate Symptom Score (IPSS) questionnaire, the International Index of Erectile Function (IIEF) questionnaire and performing statistical analysis.[On day before the surgery and on 6 months.]
Secondary ID(s)
Nil
Source(s) of Monetary Support
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history